Dr Reddy’s completes Phase I study of DRL_TC, a tocilizumab biosimilar candidate
This Phase I study used an intravenous (IV) formulation to evaluate the pharmacokinetic equivalence, safety and immunogenicity of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Tocilizumab
Dr Reddy’s completes phase-I study of proposed biosimilar of Tocilizumab
Tocilizumab is an anti-rheumatic agent used in the treatment of adult patients with moderate-to-severe active rheumatoid arthritis…
COVID treatment: Centre issues revised guidelines on use of drugs and therapies
The revised guidelines continue to recommend Emergency Use Authorisation (EUA) or off-label use of Remdesivir in patients with…
European Commission approves Actemra/RoActemra by Roche to treat severe COVID-19
Approval based on results from four phase-III studies in motre than 5,500 patients
CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19
Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase-III studies.…
Hetero gets emergency use nod to make Roche’s COVID-19 drug
Hetero expects to make the treatment, tocilizumab, available in India by the end of the month under the brand name Tocira
Health Minister reviews availability of COVID-19 essential drugs
Raw materials for the drugs are available in enough quantities
Centre increases supply of essential drugs for COVID
The availability of all major drugs required for the management of COVID-19 was regularly monitored through weekly surveys of…
COVID-19 trials and tribulations for treatments
Dr Arun Bhatt, Consultant – Clinical Research & Drug Development states that in the absence of a peer-reviewed publication in…
American civil rights leader to request US President to release 60 million COVID-19 vaccine doses to…
Rev. Jackson will be joined by a number of prominent Indian leaders in Washington to make a public appeal to Biden for more…